Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DH8FY6
|
|||
| Drug Name |
ARC1779
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Intracranial embolism [ICD-11: 8B22.1] | Phase 2 | [1] | |
| Company |
Archemix
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00742612) Effect of ARC1779 on Cerebral Microembolism in Patients Undergoing Carotid Endarterectomy. U.S. National Institutes of Health. | |||
| REF 2 | Short-Acting Anti-VWF (von Willebrand Factor) Aptamer Improves the Recovery, Survival, and Hemostatic Functions of Refrigerated Platelets. Arterioscler Thromb Vasc Biol. 2019 Oct;39(10):2028-2037. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.